Sumer Pek

2.4k total citations
60 papers, 1.9k citations indexed

About

Sumer Pek is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Sumer Pek has authored 60 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Endocrinology, Diabetes and Metabolism, 37 papers in Surgery and 18 papers in Molecular Biology. Recurrent topics in Sumer Pek's work include Pancreatic function and diabetes (37 papers), Diabetes Management and Research (17 papers) and Diabetes Treatment and Management (17 papers). Sumer Pek is often cited by papers focused on Pancreatic function and diabetes (37 papers), Diabetes Management and Research (17 papers) and Diabetes Treatment and Management (17 papers). Sumer Pek collaborates with scholars based in United States, Australia and Canada. Sumer Pek's co-authors include Stefan S. Fajans, John C. Floyd, Jerome W. Conn, Ryuzo Kawamori, Ronald E. Chance, Ralph F. Knopf, Barbara C. Hansen, Tong‐Yuan Tai, Mladen Vranić and Marcia F. McInerney and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Annals of Internal Medicine.

In The Last Decade

Sumer Pek

58 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sumer Pek United States 23 949 886 496 410 395 60 1.9k
Akira Ohneda Japan 22 1.1k 1.1× 874 1.0× 376 0.8× 390 1.0× 276 0.7× 112 1.9k
L Picon France 22 686 0.7× 720 0.8× 377 0.8× 561 1.4× 351 0.9× 69 1.8k
C. R. Morgan United States 17 1.3k 1.4× 1.0k 1.2× 813 1.6× 782 1.9× 476 1.2× 38 3.0k
L Sestoft Denmark 24 813 0.9× 434 0.5× 471 0.9× 529 1.3× 155 0.4× 86 1.8k
B. Willms Germany 19 1.6k 1.6× 907 1.0× 756 1.5× 435 1.1× 150 0.4× 56 2.3k
Tomohiko Taminato Japan 25 641 0.7× 757 0.9× 636 1.3× 376 0.9× 196 0.5× 109 2.1k
A Luyckx Belgium 26 770 0.8× 560 0.6× 310 0.6× 626 1.5× 196 0.5× 110 1.7k
Hans Kofod Denmark 22 1.5k 1.6× 1.4k 1.5× 853 1.7× 378 0.9× 508 1.3× 47 2.7k
Hideo Manaka Japan 20 1.1k 1.2× 370 0.4× 637 1.3× 359 0.9× 160 0.4× 55 2.1k
Anna M. Eisentraut United States 22 2.0k 2.1× 1.7k 1.9× 853 1.7× 804 2.0× 469 1.2× 29 3.5k

Countries citing papers authored by Sumer Pek

Since Specialization
Citations

This map shows the geographic impact of Sumer Pek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sumer Pek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sumer Pek more than expected).

Fields of papers citing papers by Sumer Pek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sumer Pek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sumer Pek. The network helps show where Sumer Pek may publish in the future.

Co-authorship network of co-authors of Sumer Pek

This figure shows the co-authorship network connecting the top 25 collaborators of Sumer Pek. A scholar is included among the top collaborators of Sumer Pek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sumer Pek. Sumer Pek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pek, Sumer, et al.. (1990). Lipoxygenase-generated icosanoids inhibit glucose-induced insulin release from rat islets. Prostaglandins Leukotrienes and Essential Fatty Acids. 40(1). 21–25. 15 indexed citations
2.
Pek, Sumer, et al.. (1990). Protein phosphorylation in pancreatic islets induced by 3-phosphoglycerate and 2-phosphoglycerate.. Proceedings of the National Academy of Sciences. 87(11). 4294–4298. 9 indexed citations
3.
Hansen, Barbara C., et al.. (1985). Fluctuations in basal plasma levels of pancreatic polypeptide in monkeys and humans. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 248(6). R739–R747. 2 indexed citations
4.
Cohen, David & Sumer Pek. (1984). Selective effects of secretagogues on insulin secretion: A mathematical model. Computers in Biology and Medicine. 14(2). 191–207. 2 indexed citations
5.
Morgan, Reginald O. & Sumer Pek. (1984). Role of arachidonate lipoxygenase and cyclooxygenase products in insulin and glucagon secretion from rat pancreatic islets. Metabolism. 33(10). 928–935. 13 indexed citations
6.
Pek, Sumer, et al.. (1982). Modulatory role of prostaglandins in regulation of secretion of insulin and glucagon. 291–296. 2 indexed citations
7.
Pek, Sumer, et al.. (1979). Glucagon-Insulin Interactions in Patients with Insulin-Producing Pancreatic Islet Lesions*. The Journal of Clinical Endocrinology & Metabolism. 48(2). 201–206. 5 indexed citations
9.
Berger, Dave K., et al.. (1978). Effect of Age on Fasting Plasma Levels of Pancreatic Hormones in Man*. The Journal of Clinical Endocrinology & Metabolism. 47(6). 1183–1189. 53 indexed citations
10.
Pek, Sumer. (1977). 3 Glucagon and diabetes. Clinics in Endocrinology and Metabolism. 6(2). 333–344. 4 indexed citations
11.
Tai, Tong‐Yuan & Sumer Pek. (1976). Direct Stimulation by Growth Hormone of Glucagon and Insulin Release from Isolated Rat Pancreas. Endocrinology. 99(3). 669–677. 43 indexed citations
12.
Vranić, M., Ryuzo Kawamori, Sumer Pek, Nada Kovačević, & Gerald A. Wrenshall. (1976). The essentiality of insulin and the role of glucagon in regulating glucose utilization and production during strenuous exercise in dogs.. Journal of Clinical Investigation. 57(2). 245–255. 122 indexed citations
13.
Pek, Sumer, et al.. (1975). Stimulation by prostaglandin E2 of glucagon and insulin release from isolated rat pancreas. Prostaglandins. 10(4). 493–502. 10 indexed citations
14.
Cherrington, Alan D., Ryuzo Kawamori, Sumer Pek, & M. Vranić. (1974). Arginine Infusion in Dogs: Model for the Roles of Insulin and Glucagon in Regulating Glucose Turnover and Free Fatty Acid Levels. Diabetes. 23(10). 805–815. 28 indexed citations
15.
Fajans, Stefan S., Halvor N. Christensen, John C. Floyd, & Sumer Pek. (1974). Stimulation of Insulin and Glucagon Release in the Dog by a Nonmetabolizable Arginine Analog1. Endocrinology. 94(1). 230–233. 9 indexed citations
16.
Floyd, John C., Stefan S. Fajans, Sumer Pek, et al.. (1970). Synergistic Effect of Essential Amino Acids and Glucose upon Insulin Secretion in Man. Diabetes. 19(2). 109–115. 105 indexed citations
17.
Floyd, John C., Stefan S. Fajans, Sumer Pek, et al.. (1970). Synergistic Effect of Certain Amino Acid Pairs upon Insulin Secretion in Man. Diabetes. 19(2). 102–108. 49 indexed citations
18.
Baker, Burton L., et al.. (1970). Identification of the corticotropin cell in rat hypophyses with peroxidase‐labeled antibody. The Anatomical Record. 166(4). 557–567. 47 indexed citations
19.
Conn, Jerome W., et al.. (1969). Mechanisms and Management of Hyperosmolar Coma Without Ketoacidosis in the Diabetic. Diabetes. 18(2). 111–116. 32 indexed citations
20.
Pek, Sumer, et al.. (1969). The course of asymptomatic diabetes in young people, as determined by levels of blood glucose and plasma insulin.. PubMed. 82. 211–24. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026